03/19/2024 7:30 AM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024 7:32 AM | PureTech Health (Subject) PureTech Health plc (Subject)
| Form SC TO-C | |
03/18/2024 3:30 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/04/2024 3:51 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2023 5:30 AM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023 3:30 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/02/2023 3:30 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023 3:30 PM | GELESIS HOLDINGS, INC. (Issuer) GELESIS HOLDINGS, INC. (Issuer) PureTech Health LLC (Reporting) PureTech Health (Reporting) PureTech Health plc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 3:30 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2023 5:33 AM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023 3:30 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023 3:30 PM | GELESIS HOLDINGS, INC. (Issuer) GELESIS HOLDINGS, INC. (Issuer) PureTech Health LLC (Reporting) PureTech Health (Reporting) PureTech Health plc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:32 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2023 3:31 PM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023 4:30 PM | GELESIS HOLDINGS, INC. (Issuer) GELESIS HOLDINGS, INC. (Issuer) PureTech Health LLC (Reporting) PureTech Health (Reporting) PureTech Health plc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2023 6:11 AM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/28/2023 5:07 AM | PureTech Health (Filer) PureTech Health plc (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |